Coagulation Analyzers Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

Coagulation Analyzers are a type of device that capable of measuring blood clotting characteristics such as thrombosis, hemophilia, and blood disorders. These instruments are generally regulated as device. The growth in blood disorders & infections expand the global market for Coagulation Analyzers. Market growth will also be navigated by an increase in R&D and the development of more complex formulations such as many therapies and tests. as per the World Federation of Hemophilia, 2021 It is estimated that up to 1% of the world's population suffers from VWD, but because many people have only very mild symptoms, only a small number of them know they have it. Research has shown that as many as 9 out of 10 people with VWD have not been diagnosed. Therefore, the increase in cases of several other blood diseases such as increasing population base suffering from lifestyle associated disease, and chronic blood disorders will activate the market revenue.

According to UnivDatos Market Insights (UMI)’ research report “Coagulation Analyzers Market”, the market is expected to witness a CAGR growth of around XX% during the forecast period 2021-2028F. This can be mainly attributed to increase in government funding coupled with rising number of research institutes getting involved in discovering new technologies and therapies, including Coagulation Analyzers.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=19823

Based on Test type, the Coagulation Analyzers Market is segmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimer testing, platelet function tests, other coagulation Tests. In 2020, Prothrombin Time Testing category dominated the market. This is mainly due to the rising geriatric population coupled with unhealthy lifestyle and hormonal imbalance across the globe. This growth is estimated due to increasing combination of immunological, chromogenic with a photo-optical technique which has led to the expansion of high performance, multipurpose optical hemostasis analyzers. For instance, key players in global coagulation analyzer market are focusing on development of new technological advancements with additional parameters. The high prevalence of cardiovascular diseases coupled with a high treatment rate, presence of advance technology, and government initiatives to increase the treatment rate is estimated to drive the market at a higher growth rate.

Based on End User, the market is bifurcated into the market is bifurcated into hospitals and clinics, diagnostic centers, research institutes and others. In 2020, Diagnostic Centers category accounted for the majority share in the global market. Furthermore, the availability of advanced equipment, which has higher accuracy and features to perform multiple tests, is another vital driver for the growth. For instance, as per OCED, the government spending on healthcare in the United States was 8,032.6 USD per capita which increased to 9,386.5 USD per capita in 2019. Furthermore, the presence of well-established infrastructure in hospitals, better reimbursement policies, and availability of advanced technologies and well-trained healthcare professionals is also one of the main reasons why patients prefer hospitals & clinics for wound care.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=19823

Asia-Pacific is expected to witness highest growth

Based on regions, the report provides detailed analysis for overall demand of Coagulation Analyzers for major regions including North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, India, Japan, Australia, Rest of Asia-Pacific); and Rest of World. Growing aging population coupled with presence of major pharmaceutical companies in the region would increase the development of analyzers and therapies for treatment of coagulation in countries such as India, China, and other developing Asian countries. 

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Coagulation Analyzers Market are Abbott Laboratories Inc., Danaher, Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific Corporation, F. Hoffmann-La Roche Ltd., HORIBA Medical, Nihon Kohden Corporation, Maccura Biotechnology Co., Ltd., Bio-Group Medical System. These companies are investing heavily on Coagulation Analyzers devices and assay kits to help research organizations in their studies.

§ In December 2020, Nihon Kohden has launched an Automated Hematology Coagulation and ESR Analyzer to measure complete blood count and erythrocyte sedimentation rate simultaneously and to provide test results for understanding the clinical condition of patients.

§ In July 2020, Sysmex has launched next-generation automated hemostasis coagulation analyzers CN-3000 and CN-6000 to enhance the quality of life of patients suffering from thrombotic and bleeding disorders and to increase the number of tests performed for therapy monitoring and diagnoses.

“Coagulation Analyzers Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go to market strategies and identifying the blue ocean for its offerings.   

For More Informative Information, Please Visit Us – https://univdatos.com/report/coagulation-analyzers-market/  

Market Segmentation:

1.     By Product type (Analyzers, Clinical Laboratory Analyzers, Point Of Care Analyzers, Consumables, Others)

2.     By Test type (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimer Testing, Platelet Function Tests, Other Coagulation Tests)

3.     By Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, Others)

4.     By End user (Hospitals and Clinics, Diagnostic Centers, Research Institutes, Others)

5.     By Region (North America, Europe, Asia-Pacific, Rest of World)

6.     By Company (Abbott Laboratories Inc., Danaher, Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific Corporation, F. Hoffmann-La Roche Ltd., HORIBA Medical, Nihon Kohden Corporation, Maccura Biotechnology Co., Ltd., Bio-Group Medical System)

Key questions answered in the study:

1.     What are the current and future trends of the Coagulation Analyzers industry?

2.     How the industry has been evolving in terms of distribution channel and route of administration category?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the Coagulation Analyzers industry?

5.     What is the customer orientation, purchase behavior, and expectations from the Coagulation Analyzers product suppliers across various countries?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COAGULATION ANALYZERS MARKET COVID-19 IMPACT

6 COAGULATION ANALYZERS MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

8 MARKET INSIGHTS BY TEST TYPE

9 MARKET INSIGHTS BY TECHNOLOGY

10 MARKET INSIGHTS BY END USER

11 MARKET INSIGHTS BY REGION

12 COAGULATION ANALYZERS MARKET DYNAMICS

13 COAGULATION ANALYZERS MARKET OPPORTUNITIES

14 COAGULATION ANALYZERS MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

17 COMPETITIVE SCENARIO

18 COMPANY PROFILED

19 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights –

·       Healthcare Analytics Market to Reach US$ 118.2 Billion by 2027 Globally |CAGR: 31%|

·       Smart Healthcare Technologies and Product Market to Reach US$ 78.8 Billion by 2027 Globally |CAGR: 7.15%|

·       Patient Self-Service Kiosk Market to Reach US$ 1,637.5 Million by 2026 Globally | CAGR: 16.2%|

·       Precision Medicine Market to Reach US$ 105.6 Billion by 2026, Globally |CAGR: 9.9%|